article thumbnail

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Pharmacy Times

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

article thumbnail

N-FIS was developed to address a critical challenge in healthcare—needle phobia

Express Pharma

The technology is rapidly gaining traction among doctors in India, while internationally, institutions like Hungarys Heim Pl National Paediatric Institute, one of the largest paediatric hospitals has adopted N-FIS to enhance patient care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DoH and Children’s National Hospital link for cell and gene therapy

Pharmaceutical Technology

The Department of Health – Abu Dhabi (DoH) in the United Arab Emirates (UAE) and US Children’s National Hospital (known as the Children’s National) have signed a memorandum of understanding (MoU) to advance paediatric cell and gene therapy. Data Insights The gold standard of business intelligence.

article thumbnail

Can rare disease research in the US thrive under the new administration?

Pharmaceutical Technology

Nonetheless, one of the significant outcomes of the Hub’s work has been setting up the framework for the Rare disease Innovation Science and Exploration (RISE) workshop series, which is designed to take a deep dive into an issue relevant to the rare disease space. Give your business an edge with our leading industry insights.

article thumbnail

HPM’s Larry Houck Presenting at WCF Opioid and Fentanyl Abuse Management Congress

FDA Law Blog: Biosimilars

Houck One of the most significant issues facing hospitals and other facilities is the diversion of controlled substances meant for patients by physicians, pharmacists, nurses and other trusted healthcare employees. Employee diversion can also result in unwanted local and national publicity.

article thumbnail

57 hospital and health system CXOs to know | 2025

Beckers Hospital Review

Becker’s is proud to spotlight outstanding chief experience officers who are making a meaningful impact on the patient experience at hospitals and health systems nationwide. Vice President and Chief Experience Officer of Dayton (Ohio) Children’s Hospital. He also formerly worked as chief of staff for the Miami-Dade County commissioner.

article thumbnail

Glenmark Pharma hosts drug discovery workshop for Sion Hospital students

Express Pharma

The tour was aimed at encouraging medical students to explore new horizons in their academic journey Glenmark Pharma hosted MBBS students at one of its R&D centers in Mumbai for a special workshop on drug discovery. This year, the opportunity was extended to 74 student delegates from LTMMC (Sion Hospital).